Latest Ketones Stories
PARSIPPANY, N.J., March 19, 2015 /PRNewswire/ -- Daiichi Sankyo, Inc.
Attorneys handling Zofran lawsuits have expanded their Zofran lawsuit website to include a summary of international birth defects research from the Onder Law Firm at
--Shionogi's S-718632 investigational new drug application was submitted and is open-- WAYNE, Pa., March 17, 2015 /PRNewswire/ -- Egalet Corporation (Nasdaq: EGLT) ("Egalet"), a fully
INRTracker is the definitive free online Warfarin management tool that lets patients generate easy to read reports to help them and their doctor figure out what may be causing fluctuations in
2014 - A Year of Many Significant Milestones, with More Expected for 2015, as BDSI Continues its Growth as an Integrated Specialty Pharmaceutical Company RALEIGH, N.C., March 16, 2015 /PRNewswire/
WAYNE, Pa., March 16, 2015 /PRNewswire/ -- Egalet Corporation (Nasdaq: EGLT) ("Egalet") today reported financial results for the year ended December 31, 2014.
The San Diego injury law firm discusses birth defect allegations associated with Zofran use, as two recently filed lawsuits allege that Zofran manufacturer GlaxoSmithKline failed to inform doctors
In most states, sharing narcotic opioid painkillers is equivalent to selling heroin ITASCA, Ill., March 12, 2015 /PRNewswire-USNewswire/ -- Today the
JUPITER, Fla., and PARSIPPANY, N.J., March 12, 2015 /PRNewswire/ -- Charleston Laboratories, Inc.
--Reports positive study results for Egalet-001 15 mg and 30 mg demonstrating bioequivalence to MS Contin-- WAYNE, Pa., March 11, 2015 /PRNewswire/ -- Egalet Corporation (Nasdaq: EGLT) ("Egalet")
- The abrogation of a law by a higher authority; annulment.
More Images (1 images) »